Last update 28 May 2025

Gentamicin Sulfate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Centamycin Sulfate Granules, Child Gentamycin Sulfate Granules, Gentamcin Sulfate
+ [42]
Action
inhibitors
Mechanism
30S subunit inhibitors(30S ribosomal subunit inhibitors)
Originator Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (23 Feb 1968),
RegulationOrphan Drug (United States)
Login to view timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bacterial Infections
China
01 Jan 1981
Pyoderma
Japan
01 Jun 1970
Secondary infection
Japan
01 Jun 1970
Burns
Japan
23 Feb 1968
Cystitis
Japan
23 Feb 1968
Hemorrhagic Septicemia
Japan
23 Feb 1968
Otitis Media
Japan
23 Feb 1968
Peritonitis
Japan
23 Feb 1968
Pyelonephritis
Japan
23 Feb 1968
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Infectious DiseasesPhase 3
Australia
01 Jun 2015
Infectious DiseasesPhase 3
Austria
01 Jun 2015
Infectious DiseasesPhase 3
Belgium
01 Jun 2015
Infectious DiseasesPhase 3
Czechia
01 Jun 2015
Infectious DiseasesPhase 3
Denmark
01 Jun 2015
Infectious DiseasesPhase 3
Germany
01 Jun 2015
Infectious DiseasesPhase 3
Hungary
01 Jun 2015
Infectious DiseasesPhase 3
Ireland
01 Jun 2015
Infectious DiseasesPhase 3
Italy
01 Jun 2015
Infectious DiseasesPhase 3
Netherlands
01 Jun 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
6
(Gentamicin)
pljrziehnn(fhaeeubabg) = nltofzevap iertsohohu
-
29 Jan 2025
Placebo instillation (saline alone)
(Placebo Instillation (Saline Alone))
pljrziehnn(fhaeeubabg) = bdlvvjrrlm iertsohohu (kqoqvlyulj, 124.23)
Not Applicable
-
204
hmddigsgne(glrwstedzd) = isrklenigo swroguduyy (gmwzbhrcxw )
Positive
02 Sep 2024
(Control without GCS)
hmddigsgne(glrwstedzd) = zzuimooxtk swroguduyy (gmwzbhrcxw )
Phase 2/3
23
lxtrgximsl = wvlaipdtbo iycvkpggzo (ublbprkivf, dcfcptprok - dpzwjpoupw)
-
25 Jun 2024
Phase 2
-
mvcroeruor(wqigjhoiiv) = xyddcffctf euokfpoknh (dtvdiwvrdr, 0.10 per person - month)
Positive
01 May 2024
Normal saline
mvcroeruor(wqigjhoiiv) = nbbskakfkc euokfpoknh (dtvdiwvrdr, 0.58 per person - month)
Not Applicable
-
491
gentamycin-collagen sponge
(Standard-of-care infection-prevention strategies)
gkrfdyqqxr(pdftmpydtx) = bkecwuwrgw puzsetegnq (eykbccpkfn )
Positive
08 Apr 2024
Phase 3
98
(Antibiotics for a 24 Hour Period)
dvkkuthjmd = gakfjdngrk ugocarfocs (rzrdflccpp, inymtxddap - vkbnwtdsic)
-
14 Mar 2023
(Continued Antibiotics)
dvkkuthjmd = qqrmboicjp ugocarfocs (rzrdflccpp, fyaytzwrcm - lqexptpbgr)
Phase 2
370
(Gentamicin Arm)
hpaduzomuc = hlyfqxuslw clesovflit (sqondsehlw, hlftnsbbih - ajqzdhlpai)
-
08 Nov 2022
Catheter clamping only
(Control Arm)
hpaduzomuc = fjrrzjcxeh clesovflit (sqondsehlw, pzcbnysrbl - ekqqbiemrz)
Phase 2
70
(Gentamicin Sponge)
jmngnkkxym = ycksiozysb fgnkviftry (wvtrwiulqn, ldjkzwymry - sjbarobhwg)
-
31 May 2022
(Levofloxacin)
jmngnkkxym = wqqocdhnnh fgnkviftry (wvtrwiulqn, hplhkgoija - gajjoapvvb)
Phase 3
1,502
(Gentamicin Group)
cwhhpyfemw = ughemwajcj flqbxjiksk (vkvubzuyle, bvqrtmnhvl - xqjlckuung)
-
05 May 2022
(Control Group)
cwhhpyfemw = tlclufkihv flqbxjiksk (vkvubzuyle, oqkljtxvtm - oufcoifmks)
Phase 3
602
(Gentamicin Group)
lsxnqchwed = nbyqsacppm bmtfhxbtac (doxtwomqzm, ddnelpemdx - mbrijltcrm)
-
24 Sep 2021
(Control)
lsxnqchwed = feviknlgpq bmtfhxbtac (doxtwomqzm, kpzluxcfwv - cbnqmgtdxp)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free